Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+3.96%
-11.25%
-1.22%
+13.45%
Most Trending
+3.96%
-11.25%
-1.22%
+13.45%
04 Dec 2025$ACHC Multiple top-tier firms including RBC, UBS, and Deutsche Bank all maintained bullish ratings, with analyst targets pointing to a powerful 61.05% upside. The consistent confidence suggests strong conviction in Acadia recovery and growth trajectory within the healthcare services space.
$AGCO Oppenheimer Outperform call highlights steady optimism, with a projected 14.84% upside. This signals expectations for improving demand trends in agricultural equipment and potential operating leverage ahead.
$AMZN Back-to-back bullish reiterations from Citizens, BofA, and Wedbush all align on a 25.58% upside. Amazon long-term runway in cloud, AI, and e-commerce continues to anchor strong analyst confidence.
$BROS Dutch Bros is keeping momentum alive as RBC sticks with its Outperform rating and a 28.65% upside view. Expansion plans and brand loyalty appear to be driving the bullish forecast.
$BWMX Small Cap Consumer Research reiterates a Buy with a 31.17% upside target. Betterware direct-to-consumer model and margin profile continue to attract optimistic outlooks.
$CAPR Capricor stands out with a massive 231.98% upside projection from HC Wainwright. Specs-driven interest and biotech catalysts are clearly fueling extreme bullish expectations.
$CBL Ladenburg Thalmann initiation with a Buy and 10.20% upside suggests growing interest in the REIT turnaround and asset repositioning efforts.
$CMPX Dual bullish initiations from Canaccord and Citizens translate into an eye-catching 148.69% upside, putting Compass Therapeutics firmly on the speculative radar.
$DBVT Guggenheim Buy initiation implies a solid 19.23% upside, reflecting renewed confidence in the pipeline and repositioning potential.
$DRI Citi maintained Buy rating with a 28.96% upside indicates belief in Darden operational consistency and brand portfolio strength.
$DRVN William Blair upgrade to Outperform brings a bold 53.70% upside outlook, highlighting improving fundamentals and margin expansion potential.
$EQIX BMO upgrade to Outperform with a 35.63% upside signals confidence in Equinix data center dominance and long-term demand for digital infrastructure.
$EVTL Vertical Aerospace carries a striking 120.78% upside projection, pointing to high-risk, high-reward speculation tied to the future of urban air mobility.
$GRMN Longbow upgrade to Buy implies a 14.54% upside, as Garmin diversified revenue streams and steady innovation support a stronger outlook.
$MBOT Microbot Medical leads the list with a staggering 453.85% upside from Roth Capital Buy initiation, marking it as a high-volatility, high-potential biotech play.
$MCHP Microchip Technology common and preferred shares both show strong upside at 32.97% and 35.33% respectively, as Rosenblatt Buy rating reflects confidence in the semiconductor cycle rebound.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
TopRated
